Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Milstein is a Professor of Medicine at Stanford and directs the University’s Clinical Excellence Research Center. The Center engages faculty from Health, Computer, and Social Sciences in the discovery and replication of innovative health care delivery methods that safely lower per capita health care spending for excellent care. Before joining Stanford's faculty, his career of applied research spanned private and public sector healthcare delivery and policy. After creating a healthcare performance improvement firm that he expanded globally following its acquisition by Mercer, he co-founded three nationally influential public benefit initiatives, the Leapfrog Group in partnership with the Business Roundtable in 1998 and the Consumer Purchaser Alliance in 2001. Appointed to consecutive term as a Congressional MedPAC Commissioner, he originated two subsequently enacted legislative changes to improve the value of healthcare. He was a founding staff member and serves as the Medical Director of the Pacific Business Group on Health (PBGH), the largest employer-led regional healthcare improvement coalition in the U.S. Citing his national impact on innovation in health care policy and delivery methods, he was selected for the highest annual award of both the National Business Group on Health (NBGH) and of the American College of Medical Quality. Elected to the Institute of Medicine (now, NAM) of the National Academy of Sciences, he chaired the planning committee of its workshop series on best methods to lower per capita health care spending and improve clinical outcomes. He was educated at Harvard (BA–Economics), Tufts (MD) and UC Berkeley (MPH Healthcare Evaluation).
75 Alta Road, Stanford, CA 94305
Design national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians. Research on creation of a national index of health system productivity gain.
Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure
Low back and neck pain are among the leading causes of medical visits, lost productivity and
disability. There is an urgent need to identify effective and efficient ways of helping
subjects with acute spine pain while guiding practitioners towards high-value care. This
trial will be a block and cluster-randomized open-label multi-centered pragmatic randomized
clinical trial comparing healthcare spending and clinical outcomes for subjects with spine
pain of less than three months' duration, in whom there are no red flag signs or symptoms.
Subjects will be randomized to one of three treatment strategies: (1) usual primary care
provider-led care; (2) usual PCP-led care with spine pain treatment directed by the Identify,
Coordinate, and Enhanced decision making (ICE) care model, and (3) usual PCP-led care with
spine pain treatment directed by the Individualized Postural Therapy (IPT) care model. Our
outcomes of interest will be spine-related healthcare utilization at one year as well as pain
and functionality of the study participants.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details